Document is current

Any future updates will be listed below

A functional inflammasome activation assay discriminates between genetically proven caps patients and patients with low penetrance NLRP3 variants

Crossref DOI link: https://doi.org/10.1186/1546-0096-12-S1-P74

Published Online: 2014-09-17

Published Print: 2014-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark